Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

AZA Combined with R-GemOx for the Initial Treatment of Elderly DLBCL: an Open, Single-arm, Multicenter Clinical Study

Authors not listed

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · 2025

Abstract

This is a prospective, single-arm, multicenter, phase II clinical trial to evaluate the efficacy and safety of AZA(azacytidine)combined with the R-GemOx (rituximab, gemcitabine and oxaliplatin) regimen as first-line treatment in elderly diffuse large B-cell lymphoma (DLBCL) patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Anonymous. (2025). AZA Combined with R-GemOx for the Initial Treatment of Elderly DLBCL: an Open, Single-arm, Multicenter Clinical Study. <em>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</em>. https://clinicaltrials.gov/study/NCT06778902
Vancouver
Anonymous. AZA Combined with R-GemOx for the Initial Treatment of Elderly DLBCL: an Open, Single-arm, Multicenter Clinical Study. Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. 2025.
BibTeX
@misc{anon2025AZACom, title = {AZA Combined with R-GemOx for the Initial Treatment of Elderly DLBCL: an Open, Single-arm, Multicenter Clinical Study}, author = {Anonymous}, journal = {Daping Hospital and the Research Institute of Surgery of the Third Military Medical University}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings